Form D · Biotechnology

Cytovia, Inc.

Aventura, FL · CIK 0001936927

Offering snapshot reported Jan 26, 2023 · SEC filing

Reported sold
$1.2M
Offering amount: $5M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 11, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 26, 2023Initial$1,195,000No comparison10SEC filing
Jul 18, 2022Initial$2,525,000No comparison9SEC filing
Jul 18, 2022Initial$7,825,000No comparison14SEC filing

Offering details

Securities
Equity, Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$71.3K (estimated)
Finders' fees
$0
Form D file number
021-471911

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Ceros Financial Services, Inc.37869

Source: Form D, filed Jan 26, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jason Aryeh Director
Laurent Audoly Director
Gregory Fiore Director
Stanley Frankel Executive
Michael Friedman Director
Wei Li Executive
Michael Noonan Executive
Armin Rath Executive
Thomas Robinson Director
Luca Scavo Executive
Gilles Seydoux Director
Daniel Teper Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
18851 Ne 29 Th Avenue 2 Nd Floor
Aventura, FL, 33180